Join our journey towards a better future
Discover the latest news, events, and updates on our collaborative endeavors. Stay informed about our ongoing work, upcoming events, and progress toward our shared goals. Embracing inclusivity, we unite partners from diverse sectors and disciplines to collectively shape the future.
PRIME-ROSE kick-off event 19-20 September
Testbed Sweden Precision Cancer is attending the PRIME-ROSE kick-off in Oslo right now!
FOCUSE - The Swedish Precision Cancer Medicine Trial
FOCUSE is an initiative by Testbed Sweden Precision Health Cancer, founded by Vision Zero Cancer, Genomic Medicine Sweden and SciLifeLab, involving regulators, policymakers, payers, researchers, healthcare providers, patient advocates, and industry to drive the implementation of precision health in cancer care.
PRIME-ROSE: EU project receives 6 million EUR from EU Cancer Mission
PRIME-ROSE - A European precision cancer medicine trial network and implementation initiative funded by the EU Cancer Mission. The project was approved by the European Commission om April 23 2023.
Press release: PRIME-ROSE is now approved by the European Commission
PRIME-ROSE - A European precision cancer medicine trial network and implementation initiative funded by the EU Cancer Mission. The project was approved by the European Commission om April 23 2023.